UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025102 |
|---|---|
| Receipt number | R000028509 |
| Scientific Title | An exploratory study of dapagliflozin for the attenuation of albuminuria in patients with heart failure and type 2 diabetes mellitus |
| Date of disclosure of the study information | 2016/12/15 |
| Last modified on | 2022/06/07 10:26:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/12/01 16:03:19 | ||
| 2 | Update | 2018/01/05 22:23:36 | Recruitment status |
|
| 3 | Update | 2018/01/05 22:31:30 | Organization1 Email1 Organization2 Address2 Tel2 Email2 |
|
| 4 | Update | 2018/06/04 11:23:44 | Email |
|
| 5 | Update | 2020/06/04 06:46:25 | Target sample size |
|
| 6 | Update | 2020/06/04 07:01:13 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Zip code Address Address TEL Last name of contact person Last name of contact person Division name Division name Zip code Address Address TEL Division name Division name Address Address TEL Department Address1 Tel1 Address2 Tel2 Organization Organization Address Address Tel |
|
| 7 | Update | 2021/12/10 16:19:50 | Recruitment status Date of IRB Last follow-up date |
|
| 8 | Update | 2022/06/07 10:19:46 | Key secondary outcomes Key secondary outcomes |
|
| 9 | Update | 2022/06/07 10:26:50 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Division name Division name |
